Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate
The FEBS Journal · 2025
DOI: 10.1111/febs.70002 ↗At a glance
Journal article in The FEBS Journal, 2025. Written by Julie Sofie Bjerring and 4 co-authors. Institution: School of Medical Diagnostics and Translational Sciences, College of Health Sciences, Old Dominion University, Norfolk, VA, USA. Major MEDLINE topics: Mitochondria, Tumor Microenvironment, Breast Neoplasms. Cited 16 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIGMS NIH HHS, Old Dominion University - College of Health Sciences, Hampton Roads Biomedical Research Consortium.
Abstract (original language)
The mammary microenvironment has been shown to suppress tumor progression by redirecting cancer cells to adopt a normal mammary epithelial progenitor fate in vivo . However, the mechanism(s) by which this alteration occurs has yet to be defined. Here, we test the hypothesis that mitochondrial transfer from normal mammary epithelial cells to breast cancer cells plays a role in this redirection process. We evaluate mitochondrial transfer in 2D and 3D organoids using our unique 3D bioprinting system to produce chimeric organoids containing normal and cancer cells. We demonstrate that breast cancer tumoroid growth is hindered following interaction with mammary epithelial cells in both 2D and 3D environments. Furthermore, we show mitochondrial transfer occurs between donor mammary epithelial cells and recipient cancer cells primarily through tunneling nanotubes (TNTs) with minimal amounts seen from extracellular transfer of mitochondria, likely via extracellular vesicles (EVs). This organelle exchange results in various cellular and metabolic alterations within cancer cells, reducing their proliferative potential, and making them susceptible to microenvironmental control. Our results demonstrate that mitochondrial transfer contributes to microenvironmental redirection of cancer cells through alteration of metabolic and molecular functions of the recipient cancer cells. To the best of our knowledge, this is the first description of a 3D bioprinter‐assisted organoid system for studying mitochondrial transfer. These studies are also the first mechanistic insights into the process of mammary microenvironmental redirection of cancer and provide a framework for new therapeutic strategies to control cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Medical Diagnostics and Translational Sciences, College of Health Sciences, Old Dominion University, Norfolk, VA, USA.
ORCID profiles: Patrick Christian Sachs, Robert David Bruno
Funding
- NIGMS NIH HHS
- Old Dominion University - College of Health Sciences
- Hampton Roads Biomedical Research Consortium
- National Institute of General Medical Sciences, National Institutes Of Health
Cite
APA
Bjerring, J. S., Khodour, Y., Peterson, E. A., Sachs, P. C., & Bruno, R. D. (2025). Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate. The FEBS Journal. https://doi.org/10.1111/febs.70002
Vancouver
Bjerring JS, Khodour Y, Peterson EA, Sachs PC, Bruno RD. Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate. The FEBS Journal. 2025. doi:10.1111/febs.70002
BibTeX
@article{Bjerring2025,
author = {Bjerring, Julie Sofie and Khodour, Yara and Peterson, Emilee Anne and Sachs, Patrick Christian and Bruno, Robert David},
title = {Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70002}
}
EUVIMED